IL-17 Reporter HEK 293 Cells

HEK-Blue™ IL-17 Cells Unit size Cat. code Docs Qty Price
Human IL-17 Reporter Cells
3-7 x 10e6 cells

You may also need : Recombinant human IL-17A | View more associated products

IL-17 Reporter Cells

HEK-Blue™ IL-17 Cells signaling pathway
HEK-Blue™ IL-17 Cells signaling pathway


HEK-Blue™ IL-17 cells were engineered from the human embryonic kidney HEK293 cell line to detect bioactive human IL-17A and IL-17F, as well as human and murine IL-17E (also known as IL-25), by monitoring the activation of the NF-κB and AP-1 pathways. In addition, these cells can be used for screening anti-IL-17 and anti-IL-17 receptor antibodies.

HEK-Blue™ IL-17 cells were generated by stable transfection of the human genes encoding the IL-17RA/IL-17RC heterodimeric receptor and Act1 adaptor molecule into the human embryonic kidney HEK293 cell line. HEK-Blue™ IL-17 cells also express an NF-κB- and AP-1-inducible secreted embryonic alkaline phosphatase (SEAP) reporter gene. For your convenience, InvivoGen provides QUANTI‑Blue™ Solution, an easy and rapid means to detect and quantify SEAP activity in the cell culture supernatant. Of note, HEK-Blue™ IL-17 cells display little to no response to murine IL‑17A and IL-17F. They do not respond to human nor murine IL-17C. 


Features of HEK-Blue™ IL-17 cells:

  • High sensitivity to hIL-17A, hIL-17F, & h/m IL-17E
  • Low to no sensitivity to mIL-17A, h/mIL-17C, & mIL-17F
  • Readily assessable SEAP reporter activity
  • Functionally tested and guaranteed mycoplasma-free


Applications of HEK-Blue™ IL-17 cells:

  • Detection of hIL-17A & hIL-17F
  • Detection of h/mIL-17E (IL-25)
  • Screening of anti-IL-17 or anti-IL-17 receptor antibodies


HEK-Blue™ IL-17 Cells sensitivity to IL-17 cytokines
HEK-Blue™ IL-17 Cells sensitivity to IL-17 cytokines
Evaluation of cellular response to IL-17 cytokines in HEK-Blue™ IL-17 Cells
Evaluation of cellular response to IL-17 cytokines in HEK-Blue™ IL-17 Cells

Dose-response of HEK-Blue™ IL‑17cells to recombinant IL-17 cytokines.

Cells were stimulated with increasing concentrations of recombinant human or murine IL-17A, IL-17E, and IL-17F. After overnight incubation, the NF-κB response was determined using QUANTI‑Blue™ Solution, a SEAP detection reagent, and reading the optical density (OD) at 630 nm. EC50 values are shown as mean ± SD.

Evaluation of specificity in HEK-Blue™ IL-17 Cells
Evaluation of specificity in HEK-Blue™ IL-17 Cells

Cytokine response profile of HEK-Blue™ IL-17 cells.

Cells were stimulated with various human and murine recombinant cytokines: 10 ng/ml of hIL‑17A, mIL‑17A, hIL‑17E, mIL‑17E, hIL‑17F, mIL-17F, hIL‑17C, mIL-17C, 1x104 IU/ml of hIFN-α, hIFN-β, 100 ng/ml of hIFN-γ, and 1 ng/ml of hIL‑1β and hTNF-α. After overnight incubation, SEAP activity was assessed using QUANTI‑Blue™ Solution. HEK‑Blue™ IL-17C cells do not respond to hIL‑17B nor hIL-17D (data not shown).

Back to the top


Antibiotic resistance: Blasticidin, Hygromycin, Zeocin™

Growth medium: DMEM, 4.5 g/l glucose, 2-4 mM L-glutamine, 10% (v/v) heat-inactivated fetal bovine serum, 100 U/ml penicillin, 100 μg/ml streptomycin, 100 μg/ml Normocin™

Guaranteed mycoplasma-free

Specificity: human IL-17A, human IL-17F, and human & mouse IL-17E (IL-25)

Detection range:

  • 1- 100 ng/ml for human IL-17A
  • 1- 100 ng/ml for both human & mouse IL-17E (IL-25)
  • 3 - 100 ng/ml for human IL-17F


These cells are covered by a Limited Use License (See Terms and Conditions).

Back to the top


  • 1 vial containing of  3-7 x 106 cells
  • 2 x 1 ml HEK-Blue Selection (250X concentrate)
  • 1 ml Normocin™ (50 mg/ml)
  • 1 ml of QB reagent and 1 ml of QB buffer (sufficient to prepare 100 ml of QUANTI-Blue™ Solution, a SEAP detection reagent)

Shipped on dry ice (Europe, USA & Canada)

Back to the top


Interleukin 17 (IL-17) is a family of six closely related cytokines (IL-17A to IL-17F) which have both pro-inflammatory and anti-inflammatory activities. IL-17A and IL-17F, which can form a heterodimer, play an important role in Th17 immunity and are implicated in tumorigenesis and autoimmune diseases, whereas IL-17E (also known as IL-25) appears to promote Th2 immunity [1,2].

IL-17 cytokines exert their biological activities by binding to heterodimeric receptors containing the ubiquitous IL-17RA chain and a second IL-17R(C, B or E) chain. IL-17A and IL-17F bind to the IL-17RA/IL-17RC receptor, IL-17C binds to the IL-17RA/IL-17RE receptor, and IL-17E binds to the IL-17RA/IL-17RB receptor [1, 2]. The activated heterodimeric receptor recruits the Act1 adaptor and induces the TNF receptor-associated factor 6 (TRAF6) ubiquitylation. This triggers a signaling cascade that results in NF-κB and AP-1 activation [1].


1. Monin L. & Gaffen S.L., 2018. Interleukin 17 family cytokines: signaling mechanisms, biological activities, and therapeutic implications. Cold Spring Harb Perspect Biol. 10(4).
2. Pappu R. et al., 2011. The interleukin-17 cytokine family: critical players in host defence and inflammatory diseases. Immunology. 134: 8-16.

Back to the top


Visit our FAQ Any questions about our cell lines ? Visit our frequently asked questions page

Back to the top
Customer Service
& Technical Support
Shopping cart is empty